Key takeaways
Adlyxin (lixisenatide) and Ozempic (semaglutide) are both medications used to treat Type 2 diabetes and belong to the glucagon-like peptide-1 (GLP-1) receptor agonist class. However, they have several differences. Adlyxin is injected once daily, while Ozempic is injected once a week, making Ozempic more convenient for some people. Adlyxin has been discontinued in the United States as of January 1, 2023, whereas Ozempic is still available. Ozempic is also approved to lower the risk of heart attack, stroke, and death in people with Type 2 diabetes and heart disease, which is not an indication for Adlyxin. Common side effects of Adlyxin and Ozempic are similar and include nausea, vomiting, and diarrhea. Both medications can cause low blood sugar when taken with other diabetes medications.
